MicroRNA modulated networks of adaptive and innate immune response in pancreatic ductal adenocarcinoma

ABSTRACT: Despite progress in treatment strategies, only ~24% of pancreatic ductal adenocarcinoma (PDAC) patients survive >1 year. Our goal was to elucidate deregulated pathways modulated by microRNAs (miRNAs) in PDAC and Vater ampulla (AMP) cancers.

ORGANISM(S): synthetic construct Homo sapiens

PROVIDER: GSE125179 | GEO | 2019/05/15

REPOSITORIES: GEO